A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma
β Scribed by Theresa L. Whiteside, Lisa H. Butterfield, Paul H. Naylor, James E. Egan, John W. Hadden, Lorraine Baltzer, Gregory T. Wolf, Neil L. Berinstein
- Book ID
- 113026903
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 202 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The level of DNA adducts under the same conditions of carcinogen exposure and cell proliferation reflects an integrated measure of carcinogen metabolism and DNA repair. Therefore, such DNA adduct levels have the potential to be a biomarker for susceptibility to chemical carcinogenesis. In a pilot st
## Abstract ## BACKGROUND: Recent genetic studies have implicated p53 mutation as a significant risk factor for therapeutic failure in squamous cell carcinoma of the head and neck (SCCHN). However, in a recent metaβanalysis in the literature of p53 from major anatomical subsites (larynx, oral cavi
## Abstract YKLβ40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. Elevated serum levels of YKLβ40 are associated with poor prognosis in several malignancies. In this study, we examined the prognostic value of serum YKLβ40 before treatment and during followβup in p